Although results from experimental studies support a causal relationship between hyperglycemia and poor functional outcome after stroke, multicenter trial data presented in the SHINE, GIST-UK, or THIS trial do not yet support intervention with insulin (45–47). This evidence concerns the gene INS and stroke disorder.